Page 18 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kendall Capital Management cut its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,772 shares of the biopharmaceutical company’s stock after selling 253 shares during the period. […]

Choate Investment Advisors increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 20.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 631 shares of the biopharmaceutical company’s stock after buying an additional 109 shares during the period. Choate Investment Advisors’ holdings in Regeneron […]

Summit Trail Advisors LLC lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,102 shares of the biopharmaceutical company’s stock after purchasing an additional […]

Klingman & Associates LLC purchased a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 244 shares of the biopharmaceutical company’s stock, valued at approximately $201,000. Several other large investors have also recently […]

Harel Insurance Investments & Financial Services Ltd. boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 106.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 723 shares of the biopharmaceutical company’s stock after buying an additional […]